Following the success of a special walk-in clinic at the large vaccination centre at the Bath and West Showground near Shepton Mallet last weekend, additional walk-in dates are now available.

The second walk-in weekend special follows the latest Government announcement inviting anyone aged 18 and over to book their Covid vaccinations.

All eligible adults who have not yet had a first dose, or booked a slot through the National Booking Service (NBS), can come along to the vaccination site this weekend on:

Friday June 18, until 6pm

Sunday June 20, 10am to 6pm

Caroline Upton, clinical lead at the vaccination centre, said: "We were really pleased with attendance at the walk-in clinic last weekend, with more than 560 people coming along to the site to get their jab.

"We'd really like to encourage people in all eligible groups to come along to one of the additional walk-in clinics this weekend, if they haven't yet had a first dose of the Covid vaccine.

"We have plenty of vaccine supply available. There is no need to book, just come along – but please bear with us as it could be busy.

"Like last weekend, our friendly team of vaccinators and volunteers will be ready to welcome people to the site and keep the clinics running as smoothly as possible."

The walk-in clinics will operate at the Bath and West Showground this weekend, in addition to any existing pre-booked vaccination appointments.

People who have a confirmed booking slot for either first or second doses, should continue to attend their bookings as planned. After the weekend walk-ins, people should book as normal before attending the site.

There are a broad range of vaccination sites in Somerset on offer through the NBS including large vaccination sites, GP-led community sites and an increasing number of new pharmacy-led sites.

Vaccinations also continue to be available for anyone in priority groups 1-12 who have not yet taken up the offer of a vaccine.

All Somerset vaccination sites are following the latest JCVI preference to provide an alternative to the Oxford AstraZeneca vaccine for adults under the age of 39, without underlying health conditions.